liver-cirrhosis

Documents about liver-cirrhosis

• Satavaptan Dose-Ranging Study in the Prevention of Ascites#993318ClinicalTrials.gov
• Correlation Between Tp-Te Interval With the Degree of Disfunction in Liver Cirrhosis Based on Child Pugh Turcotte Score in Dr. Sardjito General Hospital#930425Acta Interna: The Journal of Internal Medicine
• MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis#181648ClinicalTrials.gov
• Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis#448176ClinicalTrials.gov
• Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis#841849ClinicalTrials.gov
• Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease#195417ClinicalTrials.gov
• Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD#305607PLOS
• Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis#844709ClinicalTrials.gov
• Relationship between plasma fi brinogen levels with model of end stage liver disease score in patients with liver cirrhosis#930369Acta Interna: The Journal of Internal Medicine
• Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease#862059ClinicalTrials.gov
• Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis#904751ClinicalTrials.gov
• LEOPARD Prospective Validation Cohort 1#832784ClinicalTrials.gov
• DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease#934588Koc University Digital Collections
• Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)#321573ClinicalTrials.gov
• Cirrhosis outcomes on rurality and weekend admissions revisited: A contemporary analysis of the national inpatient sample#340935PLOS
• Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic With Advanced HCC#143709ClinicalTrials.gov
• Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding#184702ClinicalTrials.gov
• SGLT-2 Inhibitors in the Treatment of Ascites#184808ClinicalTrials.gov
• LC‐Pred: A Transformer‐Based Interactive Interface for Liver Cirrhosis Prediction.#222982NCBI PubMed Central
• Lumped parameter modeling of changes in liver hemodynamics due to cirrhosis.#222999NCBI PubMed Central
• Pantoprazole After Prophylactic Endoscopic Variceal Treatment#238248ClinicalTrials.gov
• Can MRI Evaluate Beta-blocker Response in Portal Hypertension?#414376ClinicalTrials.gov
• Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical Ventilation#628613ClinicalTrials.gov
• ResNet50-SCPA-net for liver cirrhosis stage classification using MRI images.#678375NCBI PubMed Central
• Use of the French Healthcare Insurance Database#856523ClinicalTrials.gov
• The Utility of Breath Biopsy as a Screening Tool for HCC#861064ClinicalTrials.gov
• Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency#890467ClinicalTrials.gov
• Improving Performance of Paracentesis in Medical Residency Training#912568ClinicalTrials.gov
• MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease#805624ClinicalTrials.gov
• A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests#859383ClinicalTrials.gov
• Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques#800567ClinicalTrials.gov
• Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)#980269ClinicalTrials.gov
• Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis#883764ClinicalTrials.gov
• Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.#993785ClinicalTrials.gov
• Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites#901717ClinicalTrials.gov
• Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis#982052ClinicalTrials.gov
• Associations of antihypertensive medication class with liver fibrosis and mortality in US adults with MASLD.#672204PubMed
• Study of Prevalence of Eating Disorder in Liver Transplant Patients#875723ClinicalTrials.gov
• Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment#891255ClinicalTrials.gov
• Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)#966746ClinicalTrials.gov
• Small Diameter TIPS in Patients with Severe Liver Atrophy and Variceal Bleeding#353383ClinicalTrials.gov
• Radiomics-based Surrogate of Endoscopy (rEndosc) (CHESS1703)#377315ClinicalTrials.gov
• Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment#853204ClinicalTrials.gov
• Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites#859536ClinicalTrials.gov
• CORRELATION BETWEEN CHILD PUGH SCORE AND CYSTATIN C IN LIVER CIRRHOSIS PATIENTS#930354Acta Interna: The Journal of Internal Medicine
• Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS#991890ClinicalTrials.gov
• Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia#900259ClinicalTrials.gov
• Comparative Analysis of Different Tests to Evaluate Prognosis of Patients on Liver Transplant Waiting List#913074ClinicalTrials.gov
• Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation#914559ClinicalTrials.gov
• Global disparities in hepatocellular carcinoma care: insights from the ESGAR Global Abdominal Imaging Forum#970733Europe PMC